Els Goulmy | Academic Influence

Els Goulmy's AcademicInfluence.com Rankings

Els Goulmy

Biology

#3189

World Rank

#4916

Historical Rank

Immunology

#326

World Rank

#339

Historical Rank

biology Degrees

Download Badge

Biology

Els Goulmy's Degrees

PhD Immunology Leiden University
Masters Biology Leiden University

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Els Goulmy Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Els Goulmy is an eminent professor of transplantation biology, especially regarding minor histocompatibility antigen, at Leiden University. Goulmy is an expert in the area of tissue typing and belongs internationally to the absolute top of her discipline. She was awarded the Spinoza Prize in 2002.

(See a Problem?)

Els Goulmy's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia (2003) (447)
The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. (1998) (444)
Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy (1997) (348)
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. (1997) (345)
Y-antigen killing by T cells of women is restricted by HLA (1977) (332)
Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. (1999) (332)
In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens (2002) (320)
The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. (1997) (309)
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. (1999) (298)
Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease (1999) (294)
Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation (1992) (258)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region. (2003) (238)
Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. (2004) (202)
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease (1983) (187)
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. (2002) (170)
UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. (2000) (162)
Cutting edge: the HLA-A*0101-restricted HY minor histocompatibility antigen originates from DFFRY and contains a cysteinylated cysteine residue as identified by a novel mass spectrometric technique. (1999) (160)
Minor H Antigen HA-1–specific Regulator and Effector CD8+ T Cells, and HA-1 Microchimerism, in Allograft Tolerance (2004) (142)
Separation of the genetic loci for the H–Y antigen and for testis determination on human Y chromosome (1987) (134)
The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein (2001) (132)
Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation (2003) (124)
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein. (2003) (114)
Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. (1997) (106)
Immunotherapy of cancer through targeting of minor histocompatibility antigens. (2005) (106)
ALLOIMMUNITY TO HUMAN H-Y (1976) (102)
The Hematopoietic System–specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer Cells (2002) (97)
Minor histocompatibility antigens: from transplantation problems to therapy of cancer. (2006) (97)
In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. (1992) (96)
Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. (2009) (89)
Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. (2013) (89)
Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. (1995) (88)
Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. (1999) (88)
Minor histocompatibility antigens--big in tumour therapy. (2004) (86)
Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations (2007) (85)
The relevance of minor histocompatibility antigens in solid organ transplantation (2009) (85)
Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. (2005) (85)
Serum cytokine levels after HLA-identical bone marrow transplantation. (1998) (82)
Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy. (2004) (81)
A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications (2006) (77)
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells (2004) (74)
Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen. (2004) (74)
Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. (2009) (73)
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. (2003) (72)
Typing for MLC (LD). I. Lymphocytes from cousin-marriage offspring as typing cells. (1973) (71)
Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation. (2002) (71)
Identification of a Novel HLA-B60-Restricted T Cell Epitope of the Minor Histocompatibility Antigen HA-1 Locus1 (2002) (68)
Much ado about minor histocompatibility antigens. (1998) (66)
Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. (2007) (66)
Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies. (2002) (65)
Matching of the Minor Histocompatibility Antigen HLA-A1/H-Y May Improve Prognosis in Corneal Transplantation (2006) (65)
CD80-Transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. (1998) (64)
The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. (2010) (63)
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors (1979) (63)
EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: I. ABSENCE OF CORRELATION WITH CYTOTOXIC EFFECTOR CELLS (1990) (63)
EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: II. EVIDENCE OF A POSSIBLE INVOLVEMENT OF PROLIFERATIVE T CELLS (1990) (63)
Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch. (1996) (61)
Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. (1998) (59)
CELL‐MEDIATED LYMPHOLYSIS STUDIES IN RENAL ALLOGRAFT RECIPIENTS (1981) (58)
THE IMPORTANCE OF H‐Y INCOMPATIBILITY IN HUMAN ORGAN TRANSPLANTATION (1978) (56)
Mapping the H-Y gene. (1987) (54)
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation (1986) (53)
Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. (2009) (51)
Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice (2006) (51)
Hypomethylating drugs convert HA-1-negative solid tumors into targets for stem cell-based immunotherapy. (2009) (49)
Existence of mature human CD4+ T cells with genuine class I restriction (1992) (46)
Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value. (1989) (46)
HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML). (2008) (44)
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes. (2004) (44)
Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones. (1990) (43)
Soluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infections. (1998) (43)
Major histocompatibility complex-restricted H-Y-specific antibodies and cytotoxic T lymphocytes may recognize different self determinants (1982) (42)
Production, expansion, and clonal analysis of T cells with specific HLA-restricted male lysis. (1980) (42)
Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA. (2002) (42)
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors. (2011) (41)
Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies. (2003) (41)
Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer. (2005) (41)
Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells (1991) (41)
Month‐related variability in immunological test results; implications for immunological follow‐up studies (1991) (41)
HLA Class II Restricted T-Cell Reactivity to a Developmentally Regulated Antigen Shared by Leukemic Cells and CD34+ Early Progenitor Cells (1997) (39)
Expanding the immunotherapeutic potential of minor histocompatibility antigens. (2005) (37)
Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation. (1985) (37)
TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. (2007) (36)
Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors. (2008) (36)
Minor histocompatibility antigens HA-1-, -2-, and -4-, and HY-specific cytotoxic T-cell clones inhibit human hematopoietic progenitor cell growth by a mechanism that is dependent on direct cell-cell contact. (1993) (36)
Anti-self HLA may be clonally expressed (1979) (35)
Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients (2010) (34)
Functional expression of minor histocompatibility antigens on human peripheral blood dendritic cells and epidermal Langerhans cells. (1996) (34)
Investigation of Peptide Involvement in T Cell Allorecognition Using Recombinant HLA Class I Multimers1 (2005) (32)
The role of human minor histocompatibility antigens in graft failure: A mini-review (1995) (31)
HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand. (2000) (30)
The effects of stress and relaxation on thein vitro immune response in man: A meta-analytic study (1993) (30)
Recipient cytokine genotypes for TNF-&agr; and IL-10 and the minor histocompatibility antigens HY and CD31 codon 125 are not associated with occurrence or severity of acute GVHD in unrelated cord blood transplantation: A retrospective analysis1 (2002) (30)
Steric Hindrance and Fast Dissociation Explain the Lack of Immunogenicity of the Minor Histocompatibility HA-1Arg Null Allele 1 (2009) (29)
Minor histocompatibility antigens, defined by graft‐vs.‐host disease‐derived cytotoxic T lymphocytes, show variable expression on human skin cells (1991) (29)
The Human Minor Histocompatibility Antigen1 Is a RhoGAP (2013) (28)
A molecular deletion map of the Y chromosome long arm defining X and autosomal homologous regions and the localisation of the HYA locus to the proximal region of the Yq euchromatin. (1992) (27)
Blood transfusion induced changes in cell-mediated lympholysis: to immunize or not to immunize. (1991) (27)
Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia (2010) (26)
An estimation of the recombination fraction between the MLC locus and the FOUR locus. (2008) (25)
Transmaternal cell flow leads to antigen-experienced cord blood. (2012) (25)
Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients (2017) (23)
Deletion mapping of H-Y antigen to the long arm of the human Y chromosome. (1992) (22)
Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes. (1986) (22)
HY Immune Tolerance Is Common in Women without Male Offspring (2014) (22)
Role of the HLA system in transplantation. HLA compatibility in clinical transplantation. (1977) (21)
The effects of stress and relaxation on the in vitro immune response in man; a meta-analytic study. (1993) (21)
Renal transplant patients with steroid withdrawal evaluated longitudinally for their donor--specific cytotoxic T cell reactivity. (1991) (20)
Exclusive TCRVbeta chain usage of ex vivo generated minor Histocompatibility antigen HA-1 specific cytotoxic T cells: implications for monitoring of immunotherapy of leukemia by TCRBV spectratyping. (2002) (20)
Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease (1997) (19)
Conservation of minor histocompatibility antigens between human and non‐human primates (1996) (17)
Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T Cells (1982) (17)
Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. (2008) (17)
In situ detection of HY-specific T cells in acute graft-versus-host disease-affected male skin after sex-mismatched stem cell transplantation. (2012) (17)
Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. II. New subtypes of HLA-Bw35. (1984) (17)
HLA regulates postrenal transplant CML nonreactivity. (1985) (17)
In situ visualization of antigen-specific T cells in cryopreserved human tissues. (2006) (16)
Loss of the 'azoospermia factor' (AZF) on Yq in man is not associated with loss of HYA. (1993) (16)
A new strategy to improve kidney graft survival: the induction of CML nonresponsiveness. (1979) (15)
Transfusion Medicine: New Clinical Applications of Cellular Immunotherapy. (2000) (14)
Cell-mediated lysis of human hematopoietic progenitor cells. (1987) (14)
Targeting alloreactive T cells to hematopoietic system specific minor histocompatibility antigens for cellular immunotherapy of hematological malignancies after stem cell transplantation. (2002) (13)
Escherichia coli-nitroreductase suicide gene control of human telomerase reverse transcriptase-transduced minor histocompatibility antigen-specific cytotoxic T cells (2004) (13)
The influence of HLA-A2 subtype mismatch on renal allograft survival. (1992) (13)
Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation. (1993) (13)
Exogenous Addition of Minor H Antigen HA-1+ Dendritic Cells to Skin Tissues Ex Vivo Causes Infiltration and Activation of HA-1-Specific Cytotoxic T Cells. (2011) (13)
New facts on HLA genetics: are they relevant in bone marrow transplantation? (1984) (12)
HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells. (1997) (12)
Carboxyfluorescein fluorochromasia cell-mediated lympholysis. A comparative study (1981) (12)
The importance of non-HLA systems and the feasibility of the use of unrelated donors in bone marrow transplantation. (1978) (12)
Peptide Length Extension Skews the Minor HA-1 Antigen Presentation toward Activated Dendritic Cells but Reduces Its Presentation Efficiency (2010) (11)
Histocompatibility typing by cell mediated lympholysis (CML): workshop II technical standardization. (2008) (11)
We are all born as microchimera (2013) (11)
General T-cell receptor antagonists to immunomodulate HLA-A2-restricted minor histocompatibility antigen HA-1-specific T-cell responses. (2002) (10)
Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission (2015) (10)
Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells (2004) (9)
Targets for killer T cells. (1978) (8)
Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro. (2006) (8)
Recognition of an - as yet unknown - minor transplantation antigen by post-transplantation lymphocytes from an AML patient. (1982) (8)
A Distinct Pattern of Non-HLA Polymorphisms Predicts an Increased Risk for GvHD without Benefit of GvL in HLA Matched Sibling Transplants for Chronic Myeloid Leukemia (CML). (2006) (7)
Minor Histocompatibility antigens. (2002) (7)
Epstein-Barr virus infection abrogates the stimulatory capacity of B cells to a major histocompatibility complex class-II-restricted proliferative T-cell clone. (1995) (7)
The Influence of the Workshop Monoclonal Antibodies on CML, AgTR, PLT, ADCC, and NK Cell Activity. Functional Studies with Workshop Antibodies (1986) (7)
Detection of microchimerism by minor histocompatibility antigen HA-1 allele-specific nested polymerase chain reaction. (2005) (7)
Towards functional transplant donor matching by measurement of granzyme A and granzyme B production levels. (2004) (6)
Molecular typing methods for minor histocompatibility antigens. (2007) (6)
HLA-A,B Restriction of Cytotoxic T Cells (2019) (6)
Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. (1985) (6)
The recognition of abnormal sex chromosome constitution by HLA-restricted anti-H-Y cytotoxic T cells and antibody (2004) (6)
Host-directed cytotoxic activity in bone marrow-grafted patients. (1985) (5)
Induction of minor Histocompatibility antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation (1999) (5)
Impact of mismatching for Minor Histocompatibility antigens on the occurrence of Graft-versus-Host-Disease. (1985) (5)
Analysis of dendritic-cell-induced primary T-cell responses between HLA genotypically identical individuals. (1995) (5)
RECIPIENT CYTOKINE GENOTYPES FOR TNF- AND IL-10 AND THE MINOR HISTOCOMPATIBILITY ANTIGENS HY AND CD31 CODON 125 ARE NOT ASSOCIATED WITH OCCURRENCE OR SEVERITY OF ACUTE GVHD IN UNRELATED CORD BLOOD TRANSPLANTATION (2002) (4)
Alloreactive monofunctional human T cell clones expressing cytotoxic or primed lymphocyte typing reactivity as well as restricted immunogenetic specificities. (1980) (4)
Analysis of the functional epitopes on different HLA-A2 molecules (2004) (4)
Cytokine gene polymorphism of the recipient influences the development of acute GvHD in HLA mismatched cord blood transplants (1999) (4)
Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation. (2012) (4)
Significant factors influencing kidney graft survival. (1981) (3)
14th International HLA and Immunogenetics Workshop: Report on hematopoietic cell transplantation (2007) (3)
CD 80-Transfected Acute Myeloid Leukemia Cells Induce Primary Allogeneic (1998) (3)
The Human Minor Histocompatibility Antigen 1 Is a (2013) (3)
LYMPHOCYTE CLONING FROM REJECTED HUMAN KIDNEY ALLOGRAFT Recognition Repertoire of Alloreactive Τ Cell Clones (2005) (3)
Anti-host cytotoxic T cells of bone marrow transplant recipients with or without graft-versus-host disease are equally sensitive to cyclosporin A. (1996) (3)
Molecular analysis of HLA-A2.4 functional variant KLO: close structural and evolutionary relatedness to the HLA-A2.2 subtype (2004) (3)
Cytotoxic T lymphocytes directed against HLA-Bw 35-linked target determinants show differences in sensitivity toward antibiotics during sensitization period. (1982) (3)
ANALYSIS OF THE DONOR-SPECIFIC CYTOTOXIC T LYMPHOCYTE REPERTOIRE IN A PATIENT WITH A LONG TERM SURVIVING ALLOGRAFT Frequency , Specificity , and Phenotype of Donor-Reactive T Cell Receptor ( TCR )-& and TCR-y 6 + Clones ' (2001) (3)
Stress related changes in immunological and psychological variables induced by the preparation and defense of a PHD-thesis. (1995) (3)
Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers. (2007) (3)
histocompatibility antigens in healthy family members Naturally acquired tolerance and sensitization to minor (2013) (2)
Human Microtumors Generated in 3D: Novel Tools for Integrated In Situ Studies of Cancer Immunotherapies. (2016) (2)
14thInternational HLA and Immunogenetics Workshop: report on hematopoietic cell transplantation. (2007) (2)
CML studies in renal allograft recipients. (1981) (2)
Transfected human class I gene product adequately assembles minor histocompatibility antigens (2004) (2)
HLA restricted killing of male targerts by multi-transfused females in the cell mediated lympholysis test. (1979) (2)
Variation in the epitopes on the HLA-A2 molecule as recognized by HLA-A2 restricted and alloimmune HLA-A2 specific cytotoxic T lymphocytes. (1984) (2)
CML reaction between unrelated SD and LD identical individuals. (1975) (2)
MHC restricted cytotoxic T lymphocytes recognize a human transplantation antigen. (1983) (2)
CML nonreactivity after kidney transplantation. (1981) (1)
Cellular immunologic in vitro studies of kidney and bone marrow transplantation: cytotoxic T cell activity--an advantage or disadvantage? (1988) (1)
Recent developments in histocompatibility testing in bone marrow transplantation. (1978) (1)
Evidence for minor Histocompatibility expression in human skin. (1989) (1)
Analysis of the donor-specific cytotoxic T-cell repertoire in a patient with a long-term surviving kidney allograft. (1990) (1)
Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy (2006) (1)
Immunogenetic studies with in vitro generated cytotoxic lymphocytes of Cell Mediated Lympholysis (CML) non-reactive kidney graft recipients. (1983) (1)
Lifting a tip of the veil of human minor Histocompatibility antigens. (1995) (1)
Gender influences the birth order effect in HLA-identical stem cell transplantation. (2013) (1)
Identification of the human minor histocompatibility antigen HA-1 (1997) (1)
Two challenges in bone marrow transplantation. Graft-versus-Host-Disease and the unrelated donor (1983) (1)
Correlation between cytotoxic T cell response and graft versus host disease. (1986) (1)
The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect. (1987) (1)
Minor Histocompatibility antigens in GvL. (2000) (1)
Corrigendum to “The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth” [J. Reprod. Immunol. 87 (2010) 67–73] (2011) (1)
Current and future approaches of hematopoietic tumor specific cellular therapy. (2000) (1)
Detection of minor Histocompatibility antigens by MHC restricted cytotoxic T lymphocytes generated during Graft-versus-Host-Disease. (1984) (1)
System-Restricted Minor Histocompatibility Antigens Generated Cytotoxic T Lymphocytes Specific for Hematopoietic - Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo (2013) (0)
relapsed leukemia after HLA-mismatched stem cell transplantation T cells restricted by nonself HLA molecules: a potential strategy to treat specific cytotoxic - Generation of minor histocompatibility antigen HA-1 (2013) (0)
Human cellular immunotherapy of human hematological malignancies studied in NOD/SCID mice (2000) (0)
CML as an in vitro model of allograft reactions. (1981) (0)
Novel Human Class I Myosin Protein Is Derived from a Diallelic Gene Encoding a The HA-2 Minor Histocompatibility Antigen (2001) (0)
RNA expression of the minor histocompatibility antigen HA-1 is restricted to hematopoietic cells: relevance for immunotherapy of hematological malignancies (2001) (0)
Antigenic peptide has-2. (1996) (0)
Anti H-Y immunity in secondary recurrent miscarriage—immunogenetic and immunologic evidence (2011) (0)
Cytotoxicity Is Not Required for the Anti-Leukemia Efficacy of Human H-Y-Specific CD4+ T Lymphocytes In Vivo. (2009) (0)
Minor Histocompatibi ' ty Antigen-specific Cytotoxic T Cell Lines , Capable of Lysing Human Hematopoietic Progenitor Cells , Can Be Generated In Vitro by Stimulation with HLAidentical Bone Marrow Cells (2003) (0)
Abstract Session II - Immune Response (2003) (0)
Novel Mass Spectrometric Technique Cysteinylated Cysteine Residue as Identified and Contains a DFFRY Originates from HY Minor Histocompatibility Antigen Cutting Edge : The HLA-A * 0101-Restricted (1999) (0)
Immunogenicity and tolerogenicity in tissue transplantation. (1990) (0)
Recognition by Human B Cells of Foreign Antigen in the Context of the MHC: a Review (1988) (0)
Dentritic cells induce HLA-DP-specific T-cell proliferation between MLR-negative siblings (2004) (0)
Female agression against males documented. (1977) (0)
Longitudinal analysis of anti-host directed cytotoxic T cell reactivities after HLA-identical bone marrow transplantation. (1988) (0)
Contribution of bone marrow transplantation to knowledge of histocompatibility and the role of presensitization. (1982) (0)
Growth Inhibition ofClonogenicLeukemicPrecursor Cellsby Minor Histocompatibility Antigen-specific CytotoxicT Lymphocytes (1991) (0)
Requirements for retroviral targeting of a suicide gene to alloreactive memory stem T cells for adoptive immunotherapy of leukemia (2008) (0)
Minor H Antigen HA-1–speciﬁc Regulator and Effector CD8 (cid:2) T Cells, and HA-1 Microchimerism, in Allograft Tolerance (2004) (0)
minor histocompatibility antigen HA-1 Cord blood comprises antigen-experienced T cells specific for maternal (2013) (0)
Potentiation of a viral escape mechanism by an immune mediator: Tumor necrosis factor α stimulates the adenovirus E3 promoter (2007) (0)
Epstein Barr Virus-Specific T-cells grafted with Minor Histocompatibility Antigen HA-1 Specificity by Retroviral T-cell Receptor Transfer (2006) (0)
4 THE HUMAN MINOR HISTOCOMPATIBILITY ANTIGEN-1 IS A RHOGAP AND REGULATES THE ACTIN CYTOSKELETON AND CELL SPREADING (2012) (0)
Running title: HLA -A2 monomers stimulate WT1 -specifc CTL (2004) (0)
Hematopoietic system specific minor histocompatibility antigens presented by patient's mismatched HLA molecules: novel leukemia targets in HLA mismatched stem cell transplantation; a preclinical study (2000) (0)
HY T cells in skin GVHD In situ detection of HY-specific T cells in acute graft-versus-host disease–affected male skin after sex-mismatched stem cell transplantation (2012) (0)
P715 - Serum cytokine profile in bone marrow transplantation patients with and without Graft-versus-host disease (1996) (0)
HY-specific regulatory T-cells and male microchimerism are established in both parous and nulliparous females (2012) (0)
Graft versus host disease (1st Section) (2001) (0)
MHC RESTRICTED CYTOTOXIC Τ LYMPHOCYTES RECOGNIZE Α HUMAN MINOR TRANS- PLANTATION ANTIGEN (2005) (0)
Identification of target antigens associated with donor lymphocyte-induced graft-versus-leukemia reactivity in patients after allogeneic stem cell transplantation (SCT). (1999) (0)
The impact of maternal anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent miscarriage (2009) (0)
Crystal Structure of the minor histocompatibility peptide HA-1Arg in complex with HLA-A2 (2009) (0)
HLA Class I Multimers Cell Allorecognition Using Recombinant Investigation of Peptide Involvement in T (2013) (0)
ANTIGENS ARE DIFFERENTIALLY EXPRESSED ON HUMAN HEMATOPOIETIC PROGENITOR CELLS (2003) (0)
Inactivation of the transporter associated with antigen processing (TAP) by a viral ER-resident glycoprotein (1997) (0)
4: Effects of minor histocompatibility antigen mismatching on clinical outcome in HLA-matched, unrelated stem cell transplants (2007) (0)
[HLA-compatibility testing in kidney transplantation--past, present and future]. (1980) (0)
Separation of the Genetic Loci for the H-Y Antigen and for Testis Determination on Human Y Chromosome (1988) (0)
Carboxyfluoresceine fluorochromasia CML. A comparative study. (1981) (0)
Crystal Structure of a citrulline peptide variant of the minor histocompatibility peptide HA-1 in complex with HLA-A2 (2009) (0)
O86 - Identification of human minor histocompatibility antigens (1996) (0)
Seminars in HEMATÖLOGY VOL XXI , NO 2 , APRIL 1984 New Facts on HLA Genetics : Are They Relevant in Bone Marrow Transplantation ? (2005) (0)
Human microtumors generated in 3D: novel tools for integrated in situ studies of cellular immunotherapy (2012) (0)
DendrStic cells induce HLÄ-DP-specifSc T-cell prolfferatlon between MIR-negative sibiings (2005) (0)
IL-7 receptor expression identiﬁes suicide gene–modiﬁed allospeciﬁc CD8 (cid:1) T cells capable of self-renewal and differentiation into antileukemia effectors (2011) (0)
HLA-D, -DR clinical significance. A new strategy to improve kidney graft survival (1979) (0)
Recognition by human B cells of foreign antigen in the context of MHC (1988) (0)
HLA-D , DR — CLINICAL SIGNIFICANCE Α New Strategy to Improve Kidney Graft Survival : The Induction of CML Nonresponsiveness (2005) (0)
Human CD8+ T Regulatory cells with low avidity TcR specific for minor Histocompatibility antigens (2009) (0)
Requirements for Retroviral Targeting of a Suicide Gene to Alloreactive Memory Stem T Cells for Adoptive Immunotherapy of Leukemia. (2007) (0)
CML non-reactivity after kidney transplantation. (1981) (0)
Directed against Cells from Male Donors* (2003) (0)
oncoprotein proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) The minor histocompatibility antigen HA-3 arises from differential (2013) (0)
[Psychoneuroimmunology: cross-links between 'autonomic' systems]. (1989) (0)
Minor H antigens in GVHD and GVL Multi-center analyses demonstrate significant clinical effects of minor Histocompatibility antigens on GVHD and GVL after HLA matched related and unrelated stem-cell transplant Manuscript submitted for publication (2012) (0)
Human minor histocompatibility peptides: Candidates for immunotherapeutic intervention (1997) (0)
Feasibility of adaptive immunotherapy of leukemia with HA-1 minor histocompatibility peptide specific cytotoxic T cells: A preclinical study (1997) (0)
The importance of non-HLA sytems and the feasibility of the use of unrelated donors in bone marrow transplantation [proceedings]. (1978) (0)
The Impact of Minor Histocompatibility Antigens in Allogeneic Stem Cell Transplantation (2013) (0)
Minor histocompatibility antigen specific CTLs and in situ skin graft versus host reactions (2001) (0)
Minor HistocompatibilityAntigens in Biologyand Medicine (2010) (0)
Cytotoxic T Cells Generated During GvHD Can Detect Minor Histocompatibility Antigens in an HLA-Restricted Fashion (1984) (0)
Generation of CML negativity after planned bloodtransfusion in renal allograft recipients. (1979) (0)
Evaluation of the structural basis of T cell allorecognition using recombinant HLA class I multimers (2005) (0)
The enigma of good kidney graft survival in the face of poor HLA matches. (1981) (0)
27-OR: Effects of minor histocompatibility antigen mismatching on clinical outcome in HLA-matched, unrelated hematopoietic stem cell transplants (2007) (0)
Cytotoxic t cells generated during graft vs. host disease can detect minor histocompatibility antigens in an hla restricted fashion (1984) (0)
Allospecific Memory T Cells: Antagonistic Or Beneficial To Transplant Tolerance? (2006) (0)

This paper list is powered by the following services:

Other Resources About Els Goulmy

en.wikipedia.org

What Schools Are Affiliated With Els Goulmy?

Els Goulmy is affiliated with the following schools:

Image Attributions

Image Source for Els Goulmy